Catarina Flyborg

Catarina Flyborg is an accomplished professional in the life sciences sector, currently serving as a Senior Advisor at LSI Life Science Invest AB and as a Board Director at both BioLamina and CCRM Nordic. Additionally, Catarina is a Fellow of the Royal Swedish Academy of Engineering Sciences since January 2022. Previously, Catarina held significant roles at Cytiva, including Strategic Advisor and VP of Cell & Gene Therapy, where contributions were made to advancing next-generation therapies. Experience also includes leadership positions at GE Healthcare, where Catarina served as General Manager for Commercial and Marketing Cell Therapy, as well as roles focused on vaccine initiatives and communication. Catarina's educational background includes MSc degrees in Biochemistry and Chemistry from KTH Royal Institute of Technology and Chalmers University of Technology, respectively, and participation in the Novare Board Program at Novare Leadership Academy.